Based on recent findings, we believe that the prostate microbiome may possess a significant role in the PC metastasis, the regulation of PCSC gene expression, and a vital regulator of known PC risk factors, including elevated prostate-specific antigen (PSA) and androgen levels. The gene discussed is KLK3; the disease is pachyonychia congenita.